Debate over optimal cancer drug dosing intensifies

A new discussion has emerged over whether cancer patients are receiving excessive amounts of medication. The topic is part of a broader biotech news roundup that also includes Moderna's stock volatility and the use of AI in scientific writing. The question of appropriate dosing remains a critical issue in oncology.